Regulation of cardiac stem cells by microRNAs: State-of-the-art

Area of Science:

• Biomedical Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Stem cells show therapeutic promise for cardiovascular diseases when conventional treatments fail.
• Cardiac stem cells (CSCs) are a key source for cell-based cardiovascular therapies, supporting physiological needs and regenerating myocardial cells under pathological conditions.
• The precise molecular mechanisms governing CSC regulation, particularly the role of microRNAs (miRNAs), remain incompletely understood.

Purpose of the Study:

• To review and discuss the current evidence on the role of microRNAs (miRNAs) in regulating cardiac stem cells (CSCs).
• To explore how miRNAs influence the physiological and pathological behavior of CSCs.
• To highlight the potential of targeting miRNA pathways for novel cardiovascular disease treatments.

Main Methods:

• Literature review of existing studies on miRNAs and CSCs.
• Analysis of research investigating miRNA-mediated gene expression regulation in stem cells.
• Synthesis of findings related to miRNA involvement in CSC proliferation and differentiation.

Main Results:

• MicroRNAs (miRNAs) are small, non-coding RNA molecules that significantly regulate gene expression.
• Aberrant miRNA expression is observed in pathological conditions, affecting stem cell behavior.
• Specific miRNAs play substantial roles in controlling both the normal and abnormal proliferation and differentiation of stem cells, including CSCs.

Conclusions:

• MicroRNAs are critical regulators of cardiac stem cell (CSC) function.
• Elucidating miRNA regulatory pathways in CSCs is essential for advancing stem cell-based cardiovascular therapies.
• Targeting miRNAs offers a promising avenue for in vitro modulation of CSCs to develop innovative treatments for cardiovascular diseases.